维普中文期刊产品整合服务
9篇 您的检索式:作者名="Chigusa Morizane"
    题名 作者 年代 出处 被引量
1Familial pancreatic cancer: Concept, management and issues显示文摘Familial pancreatic cancer (FPC) is broadly defined as two first-degree-relatives with pancreatic cancer (PC) and accounts for 4%-10% of PC. Several genetic syndromes, including Peutz-Jeghers syndrome, hereditary pancreatitis, hereditary breast-ovarian cancer syndrome(HBOC), Lynch syndrome, and familial adenomatous polyposis (FAP), also have increased risks of PC, but the narrowest definition of FPC excludes these known syndromes. When compared with other familial tumors, proven genetic alterations are limited to a small proportion (<20%) and the familial aggregation is usually modest. However, an ethnic deviation (Ashkenazi Jewish>Caucasian) and a younger onset are common also in FPC. In European countries, 'anticipation' is reported in FPC families, as with other hereditary syndromes; a trend toward younger age and worse prognosis is recognized in the late years. The resected pancreases of FPC kindred often show multiple pancreatic intraepithelial neoplasia (Pan IN) foci, with various K-ras mutations, similar to colorectal polyposis seen in the FAP patients. As with HBOC patients, a patient who is a BRCA mutation carrier with unresectable pancreatic cancer (accounting for 0%-19% of FPC patients) demonstrated better outcome following platinum and Poly (ADP-ribose) polymerase inhibitor treatment. Western countries have established FPC registries since the 1990 s and several surveillance projects for highrisk individuals are now ongoing to detect early PCs. Improvement in lifestyle habits, including non-smoking, is recommended for individuals at risk. In Japan, the FPC study group was initiated in 2013 and the Japanese FPC registry was established in 2014 by the Japan Pancreas Society.Hiroyuki Matsubayashi Kyoichi Takaori Chigusa Morizane Hiroyuki Maguchi Masamichi Mizuma Hideaki Takahashi Keita Wada Hiroko Hosoi Shinichi Yachida Masami Suzuki Risa Usui Toru Furukawa Junji Furuse Takamitsu Sato Makoto Ueno Yoshimi Kiyozumi Susumu Hijioka Nobumasa Mizuno Takeshi Terashima Masaki Mizumoto Yuzo Kodama Masako Torishima Takahisa Kawaguchi Reiko Ashida Masayuki Kitano Keiji Hanada Masayuki Furukawa Ken Kawabe Yoshiyuki Majima Toru Shimosegawa 2017World Journal of Gastroenterology2017,23,6:5
2Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma显示文摘Shunsuke Kondo Hidenori Ojima Hitoshi Tsuda Jun Hashimoto Chigusa Morizane Masafumi Ikeda Hideki Ueno Kenji Tamura Kazuaki Shimada Yae Kanai Takuji Okusaka 2013International Journal of Clinical Oncology2013,,2:2
3Spontaneous regression of hepatocellular carcinoma显示文摘Shunsuke Kondo Takuji Okusaka Hideki Ueno Masafumi Ikeda Chigusa Morizane 2006International Journal of Clinical Oncology2006,,5:1
4Ultrasound-guided percutaneous pancreatic tumor biopsy in pancreatic cancer: a comparison with metastatic liver tumor biopsy, including sensitivity, specificity, and complications显示文摘Junichi Matsubara Takuji Okusaka Chigusa Morizane Masafumi Ikeda Hideki Ueno 2008Journal of Gastroenterology2008,,3:1
5Analysis of Prognostic Factors Affecting Survival After Initial Recurrence and Treatment Efficacy for Recurrence in Patients Undergoing Potentially Curative Hepatectomy for Hepatocellular Carcinoma显示文摘Kazuaki Shimada Yoshihiro Sakamoto Minoru Esaki Tomoo Kosuge Chigusa Morizane Masafumi Ikeda Hideki Ueno Takuji Okusaka Yasuaki Arai Kenichi Takayasu 2007Annals of Surgical Oncology2007,,8:1
6Phase I study of TAC ‐101, an oral synthetic retinoid, in Japanese patients with advanced hepatocellular carcinoma显示文摘Takuji Okusaka Hideki Ueno Masafumi Ikeda Yoriko Takezako Chigusa Morizane 2012Cancer Sci2012,,8:1
7Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients显示文摘Chigusa Morizane Takuji Okusaka Hideki Ueno Shunsuke Kondo Masafumi Ikeda Junji Furuse Ohkawa Shinichi Kohei Nakachi Shuichi Mitsunaga Yasushi Kojima Eiichiro Suzuki Makoto Ueno Tomohiro Yamaguchi 2012Cancer Chemotherapy and Pharmacology2012,,4:1
8Analysis of Prognostic Factors Affecting Survival After Initial Recurrence and Treatment Efficacy for Recurrence in Patients Undergoing Potentially Curative Hepatectomy for Hepatocellular Carcinoma显示文摘Kazuaki Shimada MD Yoshihiro Sakamoto MD Minoru Esaki MD Tomoo Kosuge MD Chigusa Morizane MD Masafumi Ikeda MD Hideki Ueno MD Takuji Okusaka MD Yasuaki Arai MD Kenichi Takayasu MD 2007Annals of Surgical Oncology2007,,8:1
9Random- ized phase Ⅱ study of gemcitabine plus S - 1 versus S - 1 in ad- vanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805) 显示文摘Chigusa Morizane Takuji Okusaka Junki Mizusawa 2013Cancer Science2013,104,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费